 | • レポートコード：TMR2008048 • 出版社/出版日：Transparency Market Research / 2020年6月 • レポート形態：英文、PDF、 221ページ • 納品方法：Eメール • 産業分類：通信 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートではいぼ治療薬の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、市場分析・予測、キーインサイト、いぼ種類別（一般ないぼ、性器いぼ、扁平いぼ、その他）分析、治療別（物理的破壊、化学破壊、免疫調節）分析、エンドユーザー別（病院、クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場分析・予測 ・キーインサイト ・いぼ治療薬の世界市場：いぼ種類別（一般ないぼ、性器いぼ、扁平いぼ、その他） ・いぼ治療薬の世界市場：治療別（物理的破壊、化学破壊、免疫調節） ・いぼ治療薬の世界市場：エンドユーザー別（病院、クリニック、その他） ・いぼ治療薬の世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Warts Therapeutics Market – Scope of the Report
TMR’s report on the global warts therapeutics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global warts therapeutics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global warts therapeutics market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global warts therapeutics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global warts therapeutics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global warts therapeutics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global warts therapeutics market.
The report delves into the competition landscape of the global warts therapeutics market. Key players operating in the global warts therapeutics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global warts therapeutics market that have been profiled in this report
Key Questions Answered in Warts Therapeutics Market Report
What is the scope of growth of product companies in the global warts therapeutics market?
What will be the Y-o-Y growth of the global warts therapeutics market between 2020 and 2030?
What is the influence of changing trends in treatment procedures on the global warts therapeutics market?
Will North America continue to be the most profitable market for warts therapeutics providers?
Which factors are anticipated to hamper the growth of the global warts therapeutics market during the forecast period?
Which are the leading companies in the global warts therapeutics market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global warts therapeutics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global warts therapeutics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, and market intelligence managers, who contributed to the production of TMR’s study on the addiction treatment market as primary research sources.
These primary and secondary research sources have provided exclusive information during interviews, which serves as a validation from the addiction treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global warts therapeutics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global warts therapeutics market more reliably and accurately.
レポート目次Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Warts Therapeutics Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
Chapter 5. Key Insights
5.1. Pipeline Analysis – Warts Therapeutics Market
5.2. Global Warts Therapeutics Market – COVID-19 Impact Analysis
5.3. Global Warts Therapeutics Market – Regulatory Scenario
Chapter 6. Global Warts Therapeutics Market Analysis and Forecast, by Warts Type
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Global Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
6.3.1. Common Warts
6.3.2. Genital Warts
6.3.3. Flat Warts
6.3.4. Others
6.4. Global Warts Therapeutics Market Attractiveness, by Warts Type
Chapter 7. Global Warts Therapeutics Market Analysis and Forecast, by Treatment Type
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Global Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
7.3.1. Physical Destruction
7.3.1.1. Freezing (Cryotherapy)
7.3.1.1.1. Liquid Nitrogen
7.3.1.1.2. Nitrous Oxide
7.3.1.1.3. Dimethyl Ether and Propane
7.3.1.2. Surgical Removal
7.3.1.3. Laser Treatment
7.3.2. Chemical Destruction
7.3.2.1. Bleomycin
7.3.2.2. Cantharidin
7.3.2.3. Salicylic acid
7.3.2.4. Others
7.3.3. Immunomodulation
7.3.3.1. Interferons
7.3.3.2. Zinc
7.3.3.3. Retinoid
7.4. Global Warts Therapeutics Market Attractiveness, by Treatment Type
Chapter 8. Global Warts Therapeutics Market Analysis and Forecast, by End-user
8.1. Key Findings / Developments
8.2. Introduction & Definition
8.3. Global Warts Therapeutics Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals
8.3.2. Clinic
8.3.3. Others
8.4. Global Warts Therapeutics Market Attractiveness, by End-user
Chapter 9. Global Warts Therapeutics Market Analysis and Forecast, by Geography/Region
9.1. Geographical Representation
9.2. Global Warts Therapeutics Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Warts Therapeutics Market Attractiveness, by Region
Chapter 10. North America Warts Therapeutics Market Analysis and Forecast
10.1. North America Warts Therapeutics Market Value Forecast, by Country , 2018–2030
10.1.1. U.S.
10.1.2. Canada
10.2. North America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
10.3. North America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
10.4. North America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
10.5. North America Warts Therapeutics Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Warts
10.5.3. By Treatment Type
10.5.4. By End-user
Chapter 11. Europe Warts Therapeutics Market Analysis and Forecast
11.1. Europe Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Europe Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
11.3. Europe Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
11.4. Europe Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
11.5. Europe Warts Therapeutics Market Attractiveness Analysis
11.5.1. By Country/Sub-region
11.5.2. By Warts Type
11.5.3. By Treatment Type
11.5.4. By End-user
Chapter 12. Asia Pacific Warts Therapeutics Market Analysis and Forecast
12.1. Asia Pacific Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
12.1.1. Japan
12.1.2. China
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of APAC
12.2. Asia Pacific Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
12.3. Asia Pacific Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
12.4. Asia Pacific Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
12.5. Asia Pacific Warts Therapeutics Market Attractiveness Analysis
12.5.1. By Country/Sub-region
12.5.2. By Warts Type
12.5.3. By Treatment Center
12.5.4. By End-user
Chapter 13. Latin America Warts Therapeutics Market Analysis and Forecast
13.1. Latin America Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of Latin America
13.2. Latin America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
13.3. Latin America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
13.4. Latin America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
13.5. Latin America Warts Therapeutics Market Attractiveness Analysis
13.5.1. By Country/Sub-region
13.5.2. By Warts Type
13.5.3. By Treatment Center
13.5.4. By End-user
Chapter 14. Middle East & Africa Warts Therapeutics Market Analysis and Forecast
14.1. Middle East & Africa Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Rest of Middle East & Africa
14.2. Middle East & Africa Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
14.3. Middle East & Africa Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
14.4. Middle East & Africa Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
14.5. Middle East & Africa Warts Therapeutics Market Attractiveness Analysis
14.5.1. By Country/Sub-region
14.5.2. By Warts Type
14.5.3. By Treatment Center
14.5.4. By End-user
Chapter 15. Competition Landscape
15.1. Competition Matrix
15.1.1. Prestige Consumer Healthcare, Inc.
15.1.2. Bausch Health Companies, Inc.
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.2.1. Prestige Consumer Healthcare, Inc.
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Bausch Health Companies, Inc.
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Phio Pharmaceuticals Corp.
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Verrica Pharmaceuticals
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Teva Pharmaceuticals Industries Ltd.
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. Mylan N.V.
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. Scholl’s Wellness Co.
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. Taro Pharmaceuticals Industries Ltd.
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Cipla Ltd.
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. GlaxoSmithKline plc
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
15.2.11. Novan, Inc.
15.2.11.1. Company Details
15.2.11.2. Company Description
15.2.11.3. Business Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Strategic Overview
15.2.12. AIM ImmunoTech, Inc.
15.2.12.1. Company Details
15.2.12.2. Company Description
15.2.12.3. Business Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Strategic Overview
15.2.13. Merck & Co., Inc.
15.2.13.1. Company Details
15.2.13.2. Company Description
15.2.13.3. Business Overview
15.2.13.4. SWOT Analysis
15.2.13.5. Strategic Overview
List of TablesTable 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 02: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 03: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 04: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing Cryotherapy, 2018–2030
Table 05: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 06: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 07: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 10: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 11: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 12: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 13: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 14: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 15: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 16: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 19: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 20: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 21: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 22: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 23: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 24: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 27: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 28: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 29: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 30: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 31: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 32: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 33: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 34: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 35: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 36: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 37: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 38: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 39: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 40: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 41: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 42: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 43: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 44: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 45: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 46: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 47: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 48: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030